South Korean E-cigarette Association sues government for economic damages.

Oct.17.2022
South Korean E-cigarette Association sues government for economic damages.
South Korea's electronic cigarette association has sued the government for causing economic losses to small e-cigarette businesses with incorrect information.

The Korean e-cigarette association has filed a lawsuit against the government, accusing it of causing economic losses to small business owners involved in the e-cigarette industry by providing incorrect information.


The Korea E-cigarette Association (KECA) has accused the government's health agency, the Ministry of Health and Welfare (MOHW), of damaging the reputation of small e-cigarette businesses and causing financial problems by urging the public to stop using liquid e-cigarettes in a press release dated February 23, 2019. KECA claimed that the basis for MOHW's decision was a notice from the US Food and Drug Administration (FDA) prohibiting the sale of liquid e-cigarettes due to the use of tetrahydrocannabinol, a main culprit in the US outbreak of severe lung illness associated with vaping that claimed eight lives and resulted in a ban on vaping products by the FDA in 2019. The South Korean Health Ministry, however, confirmed only one suspected case of lung injury related to e-cigarettes at the time of the press release and said that even that case was suspected to be from a smoker. According to a study published in the Journal of Korean Medical Science in December 2021, there have been no cases of severe pneumonia or lung injuries among users of liquid e-cigarettes. Despite these findings, KECA criticized the Health Ministry for not withdrawing its strong recommendation to suspend the use of liquid e-cigarettes and accused them of neglecting their duty. KECA also took issue with a press release issued by the Korean Disease Control and Prevention Agency (KDCA) on July 21, titled "Liquid E-cigarettes Disperse More and Farther Fine Dust than Cigarettes," saying that the measurements of fine dust by the KDCA were unavoidably higher in areas of higher humidity due to the method used in measuring them. KECA further argued that the comparison of liquid e-cigarettes and tobacco in the same environment is an inappropriate research method that fails to consider the unique characteristics of liquid e-cigarettes. KECA maintained that the government has already acknowledged that e-cigarettes are safer than tobacco, citing a 2017 test by the Ministry of Food and Drug Safety (MFDS) that found harmful substances in liquid e-cigarettes to be much lower than those in tobacco. KECA also pointed out that no tar or carbon monoxide was detected in liquid e-cigarettes, and the levels of formaldehyde and acetaldehyde were 1/20th and 1/500th those in cigarettes, respectively. Despite the significant differences in harmful substance contents, KECA protested that the Health Ministry's anti-smoking campaign has created a false perception that liquid e-cigarettes are as harmful as tobacco, causing great economic and psychological harm to e-cigarette business owners. KECA's Vice President Kim Du-hwan stated that KECA would do its utmost to win a legal battle against the government by preparing all scientific evidence and logical arguments to address the unfair treatment of small e-cigarette business owners who are unable to voice their concerns. A spokesperson for the Health Ministry responded to the lawsuit by stating that the relevant authorities would thoroughly examine the details of the complaint and work with other agencies such as KDCA and MFDS to address the issues.


Statement:


This article is compiled from third-party information and is intended solely for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only for industry-related communication and research purposes.


Due to limitations in our translation abilities, this article may not accurately reflect the original text. Please refer to the original version for precise information.


2FIRSTS maintains complete alignment with the Chinese government in its positions and statements regarding domestic, Hong Kong, Macau, Taiwan, and foreign issues.


The ownership of the compiled information belongs to the original media and authors. If there are any copyright infringements, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Russia’s Public Chamber official opposes “generational ban” on tobacco sales, citing rights concerns
Russia’s Public Chamber official opposes “generational ban” on tobacco sales, citing rights concerns
Vladislav Grib, deputy secretary of the Public Chamber of the Russian Federation, said a “generational ban” on cigarette sales—restricting sales based on year of birth—would not resolve smoking and would instead lead to human rights violations. He argued older cohorts would buy and share, and the approach would split citizens into two categories.
Jan.08 by 2FIRSTS.ai
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.
Nov.24
U.S. Washington State to Bring Synthetic Nicotine Under the Tobacco Tax System, Applying a Unified Tax Starting January 2026
U.S. Washington State to Bring Synthetic Nicotine Under the Tobacco Tax System, Applying a Unified Tax Starting January 2026
Washington State will subject all nicotine-containing products to the Tobacco Products Tax starting January 1, 2026, taxing them at 95% of the selling price. The change covers both tobacco-derived and synthetic nicotine products and requires businesses to report their inventory when the new tax system takes effect.
Dec.29 by 2FIRSTS.ai
5th Circuit Reviews FDA’s Compliance on Small-Business Impact of Vape Rule
5th Circuit Reviews FDA’s Compliance on Small-Business Impact of Vape Rule
A Fifth Circuit panel expressed doubts about whether the U.S. Food and Drug Administration complied with the Regulatory Flexibility Act when issuing its 2021 final rule on premarket tobacco product applications. Vape companies argued the FDA relied on outdated and inaccurate economic data, while the government said the challenged requirements stem from the Tobacco Control Act.
Dec.03 by 2FIRSTS.ai
JT Partners with Japan’s Year-End Music Festivals, Unveils Eight Limited-Edition Ploom AURA Front Panels
JT Partners with Japan’s Year-End Music Festivals, Unveils Eight Limited-Edition Ploom AURA Front Panels
Japan Tobacco Inc. (JT) will partner with two major year-end music festivals in Japan to set up “Ploom LOUNGE” smoking areas on-site, offering trial experiences of its Ploom AURA heated tobacco device. The company will also launch eight festival-exclusive front panels for Ploom AURA, distributed through on-site exchanges and a member lottery program.
Dec.11 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai